Acceptance of a reusable self-injection device for recombinant human growth hormone: final data from a questionnaire-based, cross-sectional, international, multicenter, observational study in pediatric patients

Abstract

BACKGROUND A questionnaire-based survey was conducted to assess attitudes toward a reusable self-injection system (SurePal™) among pediatric patients with growth disturbances who were prescribed treatment with Omnitrope(®) within routine clinical practice. METHODS This was a multicenter, observational study, incorporated into the noninterventional… (More)
DOI: 10.2147/MDER.S115933

Topics

6 Figures and Tables

Cite this paper

@inproceedings{Schnabel2016AcceptanceOA, title={Acceptance of a reusable self-injection device for recombinant human growth hormone: final data from a questionnaire-based, cross-sectional, international, multicenter, observational study in pediatric patients}, author={Dirk Schnabel and C J Partsch and Muriel Houang and Sarah Ehtisham and Helen C Johnstone and Markus Zabransky and Wieland Kiess}, booktitle={Medical devices}, year={2016} }